Two types of ectopic Cushing syndrome or a continuum? Review
Two types of ectopic Cushing syndrome (ECS) are described: ECS associated with aggressive neoplasms, and ECS with indolent and occult tumors, however, there is a lack of studies that thoroughly review their characteristics.
A systematic review was carried out on PUBMED of all the papers about the ECS, in order to better define the types of this subcategory of Cushing’s syndrome, highlighting the differential aspects between these subgroups.
It was found that in 50% of cases the prototypic “aggressive” ECS is caused by small cell lung carcinomas (SCLC). In these cases, the clinical presentation may be atypical, predominating the signs and symptoms derived from the protein catabolism. Cortisol and ACTH levels are extremely high, the clinical presentation is abrupt (< 3–6 months) and the tumor is usually advanced, being impossible a curative treatment. On the other hand, “indolent” ECS is mainly represented by carcinoid tumors (CT). In these cases the clinical presentation overlaps enormously with that of Cushing’s disease (CD). Cortisol and ACTH levels are slightly elevated, the clinical presentation is progressive (> 6 months) and the prognosis is usually good, and a curative treatment is possible in about 75% of the cases.
Although there is no absolute differentiation between the two extremes of ECS, a classification could be established in two groups, guided by its clinical and biochemical characteristics, and mainly by the type and stage of the ACTH-secreting tumor. However, a small percentage of tumors do not fit in this simple grouping, and may present both phenotypes or an intermediate one.
KeywordsEctopic Cushing syndrome Hypercortisolism Paraneoplastic Carcinoid tumor
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
- 4.Newell-Price J, Trainer P, Besser M, Grossman A (1998) The diagnosis and differential diagnosis of Cushing’s syndrome and pseudo-Cushing’s states. Endocrin Rev 19(5):647–672Google Scholar
- 20.Terzolo M, Reimondo G, Alì A, Bovio S, Daffara F, Paccotti PM et al (2011) Ectopic ACTH syndrome: molecular bases and clinical heterogeneity. Ann Oncol 12(2):S83–S7Google Scholar
- 33.Karageorgiadis AS, Papadakis GZ, Biro J, Keil MF, Lyssikatos C, Quezado MM et al (2015) Ectopic adrenocorticotropic hormone and corticotropin-releasing hormone co-secreting tumors in children and adolescents causing Cushing syndrome: a diagnostic dilemma and how to solve it. J Clin Endocrinol Metab 100(1):141–148CrossRefPubMedGoogle Scholar
- 37.Ritzel K, Beuschlein F, Berr C, Osswald A, Reisch N, Bidlingmaier M et al (2015) ACTH after 15 min distinguishes between Cushing’s disease and ectopic Cushing’s syndrome: a proposal for a short and simple CRH test. Eur J Endocrinol 173(2):197–204. https://doi.org/10.1530/EJE-14-0912 CrossRefPubMedGoogle Scholar
- 47.Deldycke A, Haenebalcke C, Taes Y (2017) Paraneoplastic Cushing syndrome, case-series and review of the literature. Acta Clin Belg 12:1–7Google Scholar
- 53.De Bruin C, Hofland LJ, Nieman LK, van Koetsveld PM, Waaijers AM, Sprij-Mooij DM et al (2012) Mifepristone effects on tumor somatostatin receptor expression in two patients with Cushing’s syndrome due to ectopic adrenocorticotropin secretion. J Clin Endocrino Metab 97(2):455–462CrossRefGoogle Scholar
- 55.Pacak K, Ilias I, Chen CC, Carrasquillo JA, Whatley M, Nieman LK (2004) The role of [18F]fluorodeoxyglucose positron emission tomography and [111In]-diethylenetriaminepentaacetate-D-Phe-pentetreotide scintigraphy in the localization of ectopic adrenocorticotropin-secreting tumors causing Cushing’s syndrome. J Clin Endocrinol Metab 89(5):2214–2221CrossRefPubMedGoogle Scholar
- 75.Kameya T, Shimosato Y, Adachi I, Abe K, Kasai N, Kimura K et al (1997) Immunohistochemical and ultrastructural analysis of medullary carcinoma of the thyroid in relation to hormone production. Am J Pathol 89(3):555–574Google Scholar